These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 12898514)

  • 21. Recruitment of osteoclast precursors by stromal cell derived factor-1 (SDF-1) in giant cell tumor of bone.
    Liao TS; Yurgelun MB; Chang SS; Zhang HZ; Murakami K; Blaine TA; Parisien MV; Kim W; Winchester RJ; Lee FY
    J Orthop Res; 2005 Jan; 23(1):203-9. PubMed ID: 15607894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions.
    Sun J; Hemler ME
    Cancer Res; 2001 Mar; 61(5):2276-81. PubMed ID: 11280798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
    Sun SG; Lau YS; Itonaga I; Sabokbar A; Athanasou NA
    J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro].
    Xiao XH; Zhou HD; Yuan LQ; Xie H; Liao EY
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2102-6. PubMed ID: 15730627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer.
    Dalberg K; Eriksson E; Enberg U; Kjellman M; Bäckdahl M
    World J Surg; 2000 Mar; 24(3):334-40. PubMed ID: 10658069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear localization of type I parathyroid hormone/parathyroid hormone-related protein receptors in deer antler osteoclasts: evidence for parathyroid hormone-related protein and receptor activator of NF-kappaB-dependent effects on osteoclast formation in regenerating mammalian bone.
    Faucheux C; Horton MA; Price JS
    J Bone Miner Res; 2002 Mar; 17(3):455-64. PubMed ID: 11874237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Basigin (murine EMMPRIN) stimulates matrix metalloproteinase production by fibroblasts.
    Li R; Huang L; Guo H; Toole BP
    J Cell Physiol; 2001 Mar; 186(3):371-9. PubMed ID: 11169976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone.
    Roux S; Amazit L; Meduri G; Guiochon-Mantel A; Milgrom E; Mariette X
    Am J Clin Pathol; 2002 Feb; 117(2):210-6. PubMed ID: 11863217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
    J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.
    Gravallese EM; Manning C; Tsay A; Naito A; Pan C; Amento E; Goldring SR
    Arthritis Rheum; 2000 Feb; 43(2):250-8. PubMed ID: 10693863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
    J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas.
    Nabeshima K; Suzumiya J; Nagano M; Ohshima K; Toole BP; Tamura K; Iwasaki H; Kikuchi M
    J Pathol; 2004 Mar; 202(3):341-51. PubMed ID: 14991900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB.
    Morgan T; Atkins GJ; Trivett MK; Johnson SA; Kansara M; Schlicht SL; Slavin JL; Simmons P; Dickinson I; Powell G; Choong PF; Holloway AJ; Thomas DM
    Am J Pathol; 2005 Jul; 167(1):117-28. PubMed ID: 15972958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation.
    Ishida M; Amano S
    J Bone Miner Metab; 2004; 22(5):415-29. PubMed ID: 15316862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upstream regulation of matrix metalloproteinase by EMMPRIN; extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque.
    Yoon YW; Kwon HM; Hwang KC; Choi EY; Hong BK; Kim D; Kim HS; Cho SH; Song KS; Sangiorgi G
    Atherosclerosis; 2005 May; 180(1):37-44. PubMed ID: 15823273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for the role of matrix metalloproteinase-13 in bone resorption by giant cell tumor of bone.
    Mak IW; Seidlitz EP; Cowan RW; Turcotte RE; Popovic S; Wu WC; Singh G; Ghert M
    Hum Pathol; 2010 Sep; 41(9):1320-9. PubMed ID: 20573369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of mRNAs for urokinase-type plasminogen activator, its receptor, and type 1 inhibitor in giant cell tumors of bone with in situ hybridization.
    Zheng MH; Fan Y; Panicker A; Smith A; Robertson T; Wysocki S; Robbins P; Papadimitriou JM; Wood DJ
    Am J Pathol; 1995 Dec; 147(6):1559-66. PubMed ID: 7495280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.
    Tang Y; Nakada MT; Kesavan P; McCabe F; Millar H; Rafferty P; Bugelski P; Yan L
    Cancer Res; 2005 Apr; 65(8):3193-9. PubMed ID: 15833850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin.
    van den Oord JJ; Paemen L; Opdenakker G; de Wolf-Peeters C
    Am J Pathol; 1997 Sep; 151(3):665-70. PubMed ID: 9284814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RANK Expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone.
    Atkins GJ; Kostakis P; Vincent C; Farrugia AN; Houchins JP; Findlay DM; Evdokiou A; Zannettino AC
    J Bone Miner Res; 2006 Sep; 21(9):1339-49. PubMed ID: 16939392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.